CEO/CSO of Progenics Pharmaceuticals Inc. (PGNX) Paul J Maddon buys 5,000 shares of PGNX on 11/01/2010 at an average price of $4.76 a share.

Progenics Pharmaceuticals Inc. has a market cap of $159 million; its shares were traded at around $4.83 with and P/S ratio of 3.3. Progenics Pharmaceuticals Inc. had an annual average earning growth of 5.6% over the past 10 years.

PGNX is in the portfolios of Paul Tudor Jones of The Tudor Group, Jim Simons of Renaissance Technologies LLC.

This is the annual revenues and earnings per share of PGNX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of PGNX.

CEO Recent Trades:

• Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 10/04/2010 at the average price of 4.99. Paul J Maddon owns at least 844,057 shares after this. The price of the stock has decreased by 3.21% since.


• Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 09/01/2010 at the average price of 4.1. Paul J Maddon owns at least 839,057 shares after this. The price of the stock has increased by 17.8% since.


• Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 08/02/2010 at the average price of 4.75. Paul J Maddon owns at least 834,057 shares after this. The price of the stock has increased by 1.68% since.


• Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 07/16/2010 at the average price of 4.99. Paul J Maddon owns at least 829,057 shares after this. The price of the stock has decreased by 3.21% since.


• Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 06/01/2010 at the average price of 4.99. Paul J Maddon owns at least 824,057 shares after this. The price of the stock has decreased by 3.21% since.

CFO Recent Trades:

• Sell: CFO Robert A Mckinney sold 4,000 shares of PGNX stock on 06/18/2010 at the average price of 6.25. Robert A Mckinney owns at least 32,925 shares after this. The price of the stock has decreased by 22.72% since.

This is the insider trade history vs. stock price of PGNX. For the complete insider trading history of PGNX, click here.

Directors and Officers Recent Trades:

• Sell: VP, Research & Development William C Olson sold 2,364 shares of PGNX stock on 06/22/2010 at the average price of 5.81. William C Olson owns at least 35,494 shares after this. The price of the stock has decreased by 16.87% since.


• Sell: Sr. VP, Medical Affairs Robert J Israel sold 6,180 shares of PGNX stock on 06/22/2010 at the average price of 5.82. Robert J Israel owns at least 31,186 shares after this. The price of the stock has decreased by 17.01% since.


• Sell: Sr. VP, Product Dev. Thomas A Boyd sold 2,409 shares of PGNX stock on 06/22/2010 at the average price of 5.74. Thomas A Boyd owns at least 36,625 shares after this. The price of the stock has decreased by 15.85% since.


• Sell: President Mark Robert Baker sold 2,328 shares of PGNX stock on 06/22/2010 at the average price of 5.66. Mark Robert Baker owns at least 26,689 shares after this. The price of the stock has decreased by 14.66% since.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool